In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United States.

Maher JM, Mendes RE, Jones M, Castanheira M, Sader HS

Open source

DOI
10.1016/j.diagmicrobio.2026.117298
Published
2026 May
Container
Diagnostic microbiology and infectious disease
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.diagmicrobio.2026.117298,
  title = {In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United States.},
  author = {Maher JM and Mendes RE and Jones M and Castanheira M and Sader HS},
  year = {2026},
  journal = {Diagnostic microbiology and infectious disease},
  doi = {10.1016/j.diagmicrobio.2026.117298},
  url = {https://doi.org/10.1016/j.diagmicrobio.2026.117298}
}

RIS

TY  - JOUR
TI  - In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United States.
AU  - Maher JM
AU  - Mendes RE
AU  - Jones M
AU  - Castanheira M
AU  - Sader HS
PY  - 2026
JO  - Diagnostic microbiology and infectious disease
DO  - 10.1016/j.diagmicrobio.2026.117298
UR  - https://doi.org/10.1016/j.diagmicrobio.2026.117298
ER  - 

APA

JM, M., RE, M., M, J., M, C., & HS, S. (2026). In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United States.. Diagnostic microbiology and infectious disease. https://doi.org/10.1016/j.diagmicrobio.2026.117298

Source records